Uli Bialucha
Chief Tech/Sci/R&D Officer at XILIO THERAPEUTICS, INC.
Profile
Uli Bialucha is currently the Chief Scientific Officer at Xilio Therapeutics, Inc. Previously, Uli held the position of Vice President-Drug Discovery at Immunitas Therapeutics, Inc. Uli completed their undergraduate degree at the University of Sussex and obtained a doctorate from University College London.
Uli Bialucha active positions
| Companies | Position | Start |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-03-31 |
Former positions of Uli Bialucha
| Companies | Position | End |
|---|---|---|
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Training of Uli Bialucha
| University of Sussex | Undergraduate Degree |
| University College London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| XILIO THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Uli Bialucha
